Boston: Life Sciences and Health Care Horizons 2023
29 March 2023 | 2:00 p.m. - 5:30 p.m. (EST)
Launching successfully in the U.S. and Europe
Dinner, drinks, and discussion on the impacts of the Inflation Reduction Act of 2022
01 December 2022 | 05:30 PM - Registration and cocktails | 06:30 PM - Dinner and discussion (EST)
We invite you to a cocktail reception and dinner with the Hogan Lovells Life Sciences and Health Care team on Thursday, December 1 at The Royal Sonesta in Cambridge.
U.S. Market access strategy at the clinical stage for all companies considering a launch: A three-part series
20 April, 4 May, and 18 May 2022
The complexity of the U.S. market access landscape means that proving safety and efficacy is no longer a guarantee of commercial success. This three-part series will provide you with the...
Summit on Controlled Substances – Regulation, Litigation, and Enforcement
29-30 May 2019
Lynn Mehler served as both co-chair and speaker at the American Conference Institute's (ACI) Summit on Controlled Substances – Regulation, Litigation, and Enforcement.
Single, Shared System Risk Evaluation and Mitigation Strategies: Opportunities and Challenges
14 May 2019
Lynn Mehler was a speaker during a Food and Drug Law Institute (FDLI) live webinar on 14 May.
Understanding DEA Regulations and FDA Interactions: A Case Study on Opioids
03 May 2019
Lynn Mehler was a panel member during a session at the Food and Drug Law Institute (FDLI) Annual Conference: Exploring Advanced Topics in Food and Drug Law.
